Arrivo BioVentures Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
2ndary - Private
- Investors
-
6
Arrivo BioVentures General Information
Description
Developer of reformulated biopharmaceutical drugs designed to identify biologics and small molecules to improve patient care. The company's drugs are produced by a new chemical entity, to identify regulatory strategies, to expedite the path through efficient clinical programs, enabling biotech companies to meet their drug demands and improve patients' lives.
Contact Information
Website
arrivobio.comCorporate Office
- 3000 RDU Center Drive
- Suite 130
- Morrisville, NC 27560-9731
- United States
Corporate Office
- 3000 RDU Center Drive
- Suite 130
- Morrisville, NC 27560-9731
- United States
Arrivo BioVentures Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | Completed | Clinical Trials - Phase 2 | ||||
| 3. Later Stage VC (Series B) | 17-Nov-2023 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC | $5.75M | $54.8M | Completed | Pre-Clinical Trials | ||
| 1. Seed Round | 25-May-2016 | $49M | $49M | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Arrivo BioVentures Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Arrivo BioVentures Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Arrivo BioVentures Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Orlando Health Ventures | Corporate Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Jazz Pharmaceuticals | Corporation | Minority | ||
| Solas BioVentures | Venture Capital | Minority |
Arrivo BioVentures FAQs
-
When was Arrivo BioVentures founded?
Arrivo BioVentures was founded in 2015.
-
Where is Arrivo BioVentures headquartered?
Arrivo BioVentures is headquartered in Morrisville, NC.
-
What is the size of Arrivo BioVentures?
Arrivo BioVentures has 15 total employees.
-
What industry is Arrivo BioVentures in?
Arrivo BioVentures’s primary industry is Drug Discovery.
-
Is Arrivo BioVentures a private or public company?
Arrivo BioVentures is a Private company.
-
What is Arrivo BioVentures’s current revenue?
The current revenue for Arrivo BioVentures is .
-
How much funding has Arrivo BioVentures raised over time?
Arrivo BioVentures has raised $100M.
-
Who are Arrivo BioVentures’s investors?
Orlando Health Ventures, , , Jazz Pharmaceuticals, and Solas BioVentures are 5 of 6 investors who have invested in Arrivo BioVentures.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
